Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.

被引：0
|
作者：
Bastos, Diogo Assed
Coelho, Rafael
Cardili, Leonardo
Galiza, Felipe
Ilario, Eder Nisi
Viana, Ublio
Murta, Claudio Bovolenta
Guglielmetti, Giuliano
Cordeiro, Mauricio
Pontes, Jose, Jr.
Muniz, David Queiroz Borges
Silva, Jamile Almeida
Mota, Jose Mauricio
De Freitas, Guilherme Fialho
Leite, Katia Ramos Moreira
Buchpiguel, Carlos Alberto
Nahas, William Carlos
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[2] Hosp Brigadeiro, Sao Paulo, Brazil
[3] Univ Sao Paulo, Med Sch, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5085
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
    Taplin, Mary-Ellen
    Montgomery, Bruce
    Logothetis, Christopher J.
    Bubley, Glenn J.
    Richie, Jerome P.
    Dalkin, Bruce L.
    Sanda, Martin G.
    Davis, John W.
    Loda, Massimo
    True, Lawrence D.
    Troncoso, Patricia
    Ye, Huihui
    Lis, Rosina T.
    Marck, Brett T.
    Matsumoto, Alvin M.
    Balk, Steven P.
    Mostaghel, Elahe A.
    Penning, Trevor M.
    Nelson, Peter S.
    Xie, Wanling
    Jiang, Zhenyang
    Haqq, Christopher M.
    Tamae, Daniel
    NamPhuong Tran
    Peng, Weimin
    Thian Kheoh
    Molina, Arturo
    Kantoff, Philip W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) : 3705 - +
  • [2] Re: Intense Androgen-Deprivation Therapy with Abiraterone Acetate plus Leuprolide Acetate in Patients with Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study Editorial Comment
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (06): : 1983 - 1983
  • [3] Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer
    Vadim S. Koshkin
    Maria C. Mir
    Pedro Barata
    Anita Gul
    Ruby Gupta
    Andrew J. Stephenson
    Jihad Kaouk
    Ryan Berglund
    Cristina Magi-Galluzzi
    Eric A. Klein
    Robert Dreicer
    Jorge A. Garcia
    [J]. Investigational New Drugs, 2019, 37 : 559 - 566
  • [4] Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer
    Koshkin, Vadim S.
    Mir, Maria C.
    Barata, Pedro
    Gul, Anita
    Gupta, Ruby
    Stephenson, Andrew J.
    Kaouk, Jihad
    Berglund, Ryan
    Magi-Galluzzi, Cristina
    Klein, Eric A.
    Dreicer, Robert
    Garcia, Jorge A.
    [J]. INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 559 - 566
  • [5] Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: A multicenter, open-labeled, single-arm phase II trial
    Zhuang, Junlong
    Wang, Yuwen
    Zhang, Shun
    Qiu, Xuefeng
    Zhou, Feng
    Fu, Yao
    Wei, Xuedong
    Xu, Linfeng
    Guo, Hongqian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 321 - 321
  • [6] Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).
    Efstathiou, Eleni
    Boukovala, Myrto A.
    Spetsieris, Nicholas
    Wen, Sijin
    Hoang, Anh
    Weldon, Justin Alexander
    Tidwell, Rebecca
    Davis, John W.
    Chapin, Brian Francis
    Corn, Paul Gettys
    Subudhi, Sumit Kumar
    Aparicio, Ana
    Pettaway, Curtis Alvin
    Pisters, Louis L.
    Papadopoulos, John N.
    Adibi, Mehrad
    Wang, Jennifer
    Zurita, Amado J.
    Logothetis, Christopher
    Troncoso, Patricia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP.
    Fleshner, Neil E.
    Hansen, Aaron Richard
    Chin, Joseph
    Winquist, Eric
    Van der Kwast, Theodorus
    Lajkosz, Katherine
    Kenk, Miran
    Berlin, Doron
    Veloso, Rosette
    Sridhar, Srikala S.
    Hamilton, Robert James
    Kulkarni, Girish S.
    Finelli, Antonio
    Zlotta, Alexandre R.
    Joshua, Anthony M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] EFFECT OF NEOADJUVANT ABIRATERONE ACETATE PLUS LEUPROLIDE ACETATE ON PSA, PATHOLOGIC RESPONSE, AND INTRAPROSTATIC/SERUM ANDROGEN LEVELS IN LOCALIZED HIGH-RISK PROSTATE CANCER: RESULTS OF A RANDOMIZED PHASE 2 STUDY
    Richie, Jerome P.
    Montgomery, Robert B.
    Logothetis, Christopher J.
    Bubley, Glenn J.
    Dalkin, Bruce L.
    Sanda, Martin G.
    Loda, Massimo F.
    Lis, Rosina T.
    True, Lawrence D.
    Troncoso, Patricia
    Genega, Elizabeth M.
    Balk, Steven P.
    Mostaghel, Elahe A.
    Penning, Trevor M.
    Nelson, Peter S.
    Xie, Wanling
    Haqq, Christopher M.
    NamPhuong Tran
    Peng, Weimin
    Tamae, Daniel
    Kheoh, Thian
    Molina, Arturo
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E272 - E272
  • [9] Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Lemaire, Celine
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Duclos, Marie
    Garant, Marie-Pierre
    Souhami, Luis
    [J]. EUROPEAN UROLOGY, 2018, 74 (04) : 432 - 441
  • [10] Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
    McKay, Rana R.
    Xie, Wanling
    Ye, Huihui
    Fennessy, Fiona M.
    Zhang, Zhenwei
    Lis, Rosina
    Calagua, Carla
    Rathkopf, Dana
    Laudone, Vincent P.
    Bubley, Glenn J.
    Einstein, David J.
    Chang, Peter K.
    Wagner, Andrew A.
    Parsons, J. Kellogg
    Preston, Mark A.
    Kilbridge, Kerry
    Chang, Steven L.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Taplin, Mary-Ellen
    [J]. JOURNAL OF UROLOGY, 2021, 206 (01): : 80 - 87
12345